DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

TWINBEECH CAPITAL LP's Holding History (CIK: 0001769646)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 210,370 Value ($000) $2,943 Avg Close $14.07 Range $10.57 - $16.97

Q1 2025

Shares 72,022 Value ($000) $979 Avg Close $19.16 Range $13.30 - $24.34

Q4 2024

Shares 254,586 Value ($000) $5,188 Avg Close $25.60 Range $19.93 - $33.33

Q1 2024

Shares 177,364 Value ($000) $3,640 Avg Close $18.79 Range $15.49 - $23.52

Q4 2023

Shares 40,580 Value ($000) $871 Avg Close $19.81 Range $15.45 - $23.81

Q1 2023

Shares 149,302 Value ($000) $3,440 Avg Close $27.52 Range $21.74 - $32.81

Q1 2022

Shares 18,046 Value ($000) $581 Avg Close $34.41 Range $28.76 - $47.47

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	210,370	$2,943	$14.07	$10.57 - $16.97
Q1 2025	72,022	$979	$19.16	$13.30 - $24.34
Q4 2024	254,586	$5,188	$25.60	$19.93 - $33.33
Q1 2024	177,364	$3,640	$18.79	$15.49 - $23.52
Q4 2023	40,580	$871	$19.81	$15.45 - $23.81
Q1 2023	149,302	$3,440	$27.52	$21.74 - $32.81
Q1 2022	18,046	$581	$34.41	$28.76 - $47.47